Not Signed In - ADHD Patch Daytrana (methylphenidate Transdermal System) Effective In Patients Converted From Oral Long-Acting Methylphenidate
Thu, 02 Nov 2006 07:00 PM EST
... Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that its Attention Deficit Hyperactivity Disorder (ADHD) patch DAYTRANA™ (methylphenidate transdermal system) is effective in patients converted to the patch from efficacious doses of their previous oral long-acting methylphenidate. [click link for full article] ...
Related Topics
- Fentanyl Skin Patches
- Estradiol Transdermal System
- Nicotine Skin Patches
- Testosterone Transdermal
- Methylphenidate
- Long-Acting Anticoagulant
- Methylphenidate ER
- Ethinyl Estradiol and Norelgestromin Transdermal System
- Lidocaine Transdermal
- Long Term Care
- Immune System
- Digestive System
- Endocrine System
- Estradiol and Norethindrone Transdermal Patch
- Health System
- Scopolamine Patch
- Clonidine
- ADHD
- Lidocaine Oral Cavity Patch
- What Your Female Patients Want to Know About Bladder Control
email this page
print this page
bookmark this page
feedback on this page
